Mortality in a cohort of patients with schizophrenia: a record linkage study
- PMID: 1868416
- DOI: 10.1177/070674379103600401
Mortality in a cohort of patients with schizophrenia: a record linkage study
Abstract
A retrospective study of mortality was conducted in which 3,623 patients with schizophrenia receiving treatment in Alberta between 1976 and 1985 were followed to the end of 1985. Vital status was determined by record linkage to the Statistics Canada Mortality Data Base. There were 301 deaths in the cohort, 97 of which were due to suicide. For all causes of death combined, the risk of mortality was approximately double that of the Alberta population; for suicide, risk was increased by a factor of 20. Mortality from circulatory, respiratory, digestive and genitourinary diseases was also greater than expected. It is estimated that those who suffer from schizophrenia have a life expectancy which is approximately 20% shorter than that of the general population. This study confirms earlier research demonstrating an increased risk of mortality associated with schizophrenia and extends those findings to specific causes of death.
Similar articles
-
Causes of the excess mortality of schizophrenia.Br J Psychiatry. 2000 Sep;177:212-7. doi: 10.1192/bjp.177.3.212. Br J Psychiatry. 2000. PMID: 11040880
-
An update of an epidemiology study at a hydrometallurgical nickel refinery in Fort Saskatchewan, Alberta.Health Rep. 1993;5(3):291-302. Health Rep. 1993. PMID: 8199331 English, French.
-
Premature Mortality Among Adults With Schizophrenia in the United States.JAMA Psychiatry. 2015 Dec;72(12):1172-81. doi: 10.1001/jamapsychiatry.2015.1737. JAMA Psychiatry. 2015. PMID: 26509694
-
Mortality in schizophrenia.Pharmacoepidemiol Drug Saf. 2007 Dec;16(12):1308-12. doi: 10.1002/pds.1496. Pharmacoepidemiol Drug Saf. 2007. PMID: 17944000 Review.
-
Causes of mortality in schizophrenia: An updated review of European studies.Psychiatr Danub. 2017 Jun;29(2):108-120. doi: 10.24869/psyd.2017.108. Psychiatr Danub. 2017. PMID: 28636568 Review.
Cited by
-
Lipid effects of psychiatric medications.Curr Atheroscler Rep. 2013 Jan;15(1):292. doi: 10.1007/s11883-012-0292-6. Curr Atheroscler Rep. 2013. PMID: 23225174 Review.
-
Modelling the treated course of schizophrenia: development of a discrete event simulation model.Pharmacoeconomics. 2005;23 Suppl 1:17-33. doi: 10.2165/00019053-200523001-00003. Pharmacoeconomics. 2005. PMID: 16416759
-
Breast Cancer Care Pathways for Women with Preexisting Severe Mental Disorders: Evidence of Disparities in France?J Clin Med. 2023 Jan 4;12(2):412. doi: 10.3390/jcm12020412. J Clin Med. 2023. PMID: 36675343 Free PMC article.
-
Drug-induced cardiovascular disorders.Drug Saf. 2007;30(9):783-804. doi: 10.2165/00002018-200730090-00005. Drug Saf. 2007. PMID: 17722970 Review.
-
Atypical antipsychotics: from potassium channels to torsade de pointes and sudden death.Drug Saf. 2005;28(1):35-51. doi: 10.2165/00002018-200528010-00003. Drug Saf. 2005. PMID: 15649104 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical